Tag Archives: PrEP

CDC Responds To End Of African PrEP

The CDC writes us this morning to note their response to the early halting of an African HIV PrEP study, which I mentioned yesterday. Pre-exposure prophylaxis (PrEP) involves taking an HIV medication as a preventive to infection. The CDC expresses disappointment with the cessation of the African study, as “this approach has already been shown to be effective in reducing …

Read More »

African HIV PrEP Study Halted

Citing poor early results, researchers have halted an African study in which women were given the HIV medication Truvada as a preventive to infection. Pre-exposure prophylaxis (PrEP) has been considered one of the more promising advances against AIDS. Women taking Truvada, made by Gilead Sciences Inc., are just as likely to get HIV as other women who have been given …

Read More »

AIDS Healthcare Foundation Denounces PrEP Study: There Is No Magic Pill

The AIDS Healthcare Foundation is denouncing the study of using existing HAART medications as a daily preventive for HIV infection. From their website, No Magic Pills: AIDS Healthcare Foundation takes the matter of HIV prevention very seriously. We are concerned about the implications of a recent study of pre-exposure prophylaxis (PrEP) using Gilead Sciences, Inc.’s drug Truvada using 2,500 gay …

Read More »

CDC Issues Interim PrEP Guidance

Last last year researchers announced some success in preventing HIV among gay men who were taking a daily dose of the HIV medication Truvada. The concept of warding off infection by pre-dosing with a medication is known as pre-exposure prophylaxis (PrEP.) But alarmed by the prospect for abuse, yesterday the CDC issued some interim PReP guidance as studies continue. CDC …

Read More »

Quote Of The Day – Michael Weinstein

“Recent headlines that heralded taking medication as a means of preventing transmission of HIV among gay men were applauded by many AIDS experts. The news came in a study of nearly 2,500 men in six countries that found that an average man taking the medication was 44 percent less likely to become infected than a control group taking a placebo. …

Read More »

Study Claims Using HIV Meds As Preventive To Infection Is Safe For Negative Gay Men

A study released at the AIDS 2010 conference in Vienna claims that using widely-prescribed HIV medications as a preventive for new infections (PrEP) is safe for HIV-negative men who have sex with men. Please note that effectiveness in preventing infection results have not yet been released on this study. Pre-exposure prophylaxis (PrEP) with tenofovir (found in Viread, Truvada and Atripla) …

Read More »

Massive PrEP Pill Study Underway

An international study on a temporary HIV prevention pill is underway. The concept is known as pre-exposure prophylaxis or PrEP. In a massive medical trial on three continents, doctors are testing a controversial pill that could temporarily boost immunity against HIV before a person is even exposed to the virus. If the pill works safely, doctors must then address whether …

Read More »